YourRad AB is Providing MVision’s AI-Powered Segmentation Service to Nordic Cancer Hospitals

Helsinki – 5th of November, 2021 – MVision AI, the pioneer of SaaS radiotherapy treatment planning optimization, announces their distribution partnership YourRad AB, the prime supplier of radiation treatment products for Nordic Clinics.

The commitment authorizes YourRad AB with the entitlement to distribute products and services of MVision AI in the Nordic region. YourRad AB and MVision AI are devoted to accelerated, prime, and guideline-based provisions of radiotherapy solutions for Nordic radiation oncology practices. The MVision AI team will collaborate with YourRad staff to assure the dispensation of superior, swift, and dependable radiotherapy services.

“We are happy and proud of the partnership with MVISION Oy. The feedback from our end users in radiotherapy have been excellent. It mainly highlights the fact that the quality and consistency are excellent and that the value for both health care professionals and patients is great. Very high quality in delineating OAR´s and time saving are the key benefits according to customers,” says M. Forss, CEO of YourRad AB. 

As stated by Mahmudul Hasan, CEO, and co-founder of MVision AI, “MVision is delighted to partner with YourRad AB to bring our guideline-based AI segmentation (GBAIS™ and GCAIS™) to Nordic customers. Nordic countries have always been at the forefront of adopting cutting-edge technologies. MVision is excited to bring more innovative solutions to facilitate same-day treatment as a reality.”

For additional information on YourRad AB:

Magasinsgatan 8C, 434 37, Kungsbacka, Sweden

Tel: +46 (0) 70 609 88 91 

Email: info@yourrad.se

LinkedIn: https://www.linkedin.com/company/yourrad-ab/?originalSubdomain=se 

For supplementary information on MVision AI: 

c/o Terkko Health Hub, Haartmaninkatu 4, 00290 Helsinki, Finland.

Tel: +358 (0) 40 5489 229

Website: https://www.mvision.ai 

Email: info@mvision.ai 

Social Media: Facebook, Instagram, LinkedIn, Twitter, and Youtube

For media inquiries:

Tel: +358 40 500 7915

Email: pr@mvision.ai

 

Our Newsletter

Subscribe to get information, latest news and other interesting offers about MVision AI

Related Posts

7.11.2024

Safe and Ethical AI in Radiation Oncology: Regulations and MVision’s Compliance

Technology is evolving, and the same applies to Radiation Oncology. New ways and new tools require new rules. Artificial intelligence (AI)  brings tremendous potential, so the world has to learn how to get the best of it, safely.  Al systems identified as high-risk have to comply with strict requirements, including…

Articles

24.10.2024

MVision AI Secures FDA 510(k) Clearance for Contour+ Advanced CT and MR Models

Helsinki, October 2024 – MVision AI, a leading innovator in AI-powered solutions for radiotherapy, is thrilled to announce that its auto-contouring solution Contour+ has received FDA 510(k) clearance for three new models: Bones CT, Brain MR, and Male Pelvis MR T2, and five updated models: Brain CT, Abdomen & Lung…

Press Releases

22.10.2024

Saving Time to Improve Workflow and Patient Comfort: A New AI-Based Solution for Gynaecological Brachytherapy

Navigating Discomfort Radiation therapy is a non-invasive and non-painful cancer treatment. However, some patients might experience mild discomfort during treatment sessions, determined by a variety of factors. Physical discomfort due to positioning and immobilisation represent one of the most common causes [1]. Despite the medical team’s efforts, keeping the same…

Articles